| Bioactivity | IPL344 protects cells of various types from pro-apoptotic pressures and activates the Akt signaling system. IPL344 can be used for research of amyotrophic lateral sclerosis (ALS)[1][2]. |
| CAS | 877120-59-7 |
| Sequence | Leu-Pro-Pro-Leu-Pro-Tyr-Pro |
| Shortening | LPPLPYP |
| Formula | C41H61N7O9 |
| Molar Mass | 795.96 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eran Ovadia, et al. Peptide compounds and methods of treating diseases using same. Patent. WO 2021/144798 Al [2]. Meglio M. Akt Activator IPL344 Demonstrates Safety, Signs of Efficacy in Phase 1/2 Study of ALS[J]. Neurology Times, 2022: NA-NA. |